Nitric oxide mediates endotoxin-induced hypertriglyceridemia through its action on skeletal muscle lipoprotein lipase

FASEB J. 2001 Aug;15(10):1828-30. doi: 10.1096/fj.00-0830fje.
No abstract available

MeSH terms

  • Adipose Tissue / enzymology
  • Animals
  • Enzyme Inhibitors / pharmacology
  • Escherichia coli
  • Guanidines / pharmacology
  • Hypertriglyceridemia / chemically induced*
  • Lipopolysaccharides / pharmacology*
  • Lipoprotein Lipase / antagonists & inhibitors*
  • Mice
  • Mice, Knockout
  • Muscle, Skeletal / enzymology*
  • Nitric Oxide / physiology*
  • Nitric Oxide Synthase / antagonists & inhibitors
  • Nitric Oxide Synthase / deficiency
  • Nitric Oxide Synthase / physiology
  • Nitric Oxide Synthase Type II
  • Rats
  • Rats, Sprague-Dawley
  • Triglycerides / blood

Substances

  • Enzyme Inhibitors
  • Guanidines
  • Lipopolysaccharides
  • Triglycerides
  • Nitric Oxide
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Nos2 protein, rat
  • Lipoprotein Lipase
  • pimagedine